Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

2 results

  • Topics : Eye diseases
  • Active substance : atropine
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Eye diseases (2)
    • Disability (1)
  • Economics and public health (1)
  • Plus ...
    • Screening, prevention (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Protheses and implants (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Manufacturer
  • inconnu (1)
Language
  • Français (2)
Active substance
  • alcool (1)
  • atropine (2)
  • ceftazidime (1)
  • chlorure de benzalkonium (1)
  • morphine (1)
  • prednisolone (1)
  • vancomycine (1)

Practice guidelines and other guides - 1 result

  • Early vision screening in children to prevent amblyopia

    Practice guidelines - Posted on 11/6/2004
    Download abstract
    Add to my selection

Drugs, devices and medical acts - 1 result

  • Assessment of an epiretinal implant and its implantation procedure

    Health technology assessment - Posted on 20/12/2012
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
WkB6zXqDsY5mtfm6